Singapore, April 12 -- The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia (COMIRNATY - BNT162b2).

These changes will enable greater flexibility in storage, transport and deployment of the Pfizer COVID-19 vaccine across Australia.

While longer term storage at dry ice or ultra-cold temperatures (-90C to -60degC) is still required, for unopened vials, storage and transportation at domestic freezer temperatures (-25degC to -15degC) is now permitted for up to 2 weeks.

Vials stored or transported in this manner can also be returned to ultra-cold longer term storage within the original shelf life of the product.

In addition, un...